Media Relations
For media inquiries please contact:
ROUTINE & CUSTOM TESTING
Specialty Capabilities
Let's Get Started
Alcami Biologics
Analytical Services
Manufacturing
Support Services
Company Overview
News & Media
Events
Join Our Team
Our team brings a founder's mentality and client-centered focus united by a common cause, entrepreneurial spirit, and a passion for customer service. Our unique combination of industry experience, technical acumen, and operational wisdom sets the stage for client success and benefits to patients around the globe. We believe these characteristics should influence everything we do in business and life. We love the work that we do, and our clients should reap the benefits.
Prior to Alcami, Humphries’ executive leadership roles included CEO at Isosceles Pharmaceuticals, President and Group Company Chairman of Ortho-Dermatologics, CEO of Merz North America, President of Stiefel, a GSK Company and Vice President of US Skincare at Allergan Pharmaceuticals. Bill is an experienced leader in the life sciences industry, serving as Chairman of the Board at Clearside Biomedical, Executive Chairman of Strata Skin Sciences, and a member of the Board of Directors at Aclaris Therapeutics, PhaseBio Pharmaceuticals, SKNV, and Bryn Pharmaceuticals. Humphries’ academic credentials include a B.A. from Bucknell University and MBA from Pepperdine University.
Ken brings over 25 years of experience in the pharmaceutical industry with considerable experience in finance, mergers, acquisitions, and information system implementations. Ken joined AAIPharma (now Alcami) in 1997 and has served in numerous financial leadership roles throughout his long-standing tenure with the company. Before rejoining Alcami, he was the Vice President and Controller of TriPharm Services, a parenteral contract manufacturing organization acquired by Alcami. Ken has a BS in Accountancy from the University of North Carolina at Wilmington.
Jamie brings more than 25 years of experience in the pharmaceutical industry, including leadership roles in engineering, manufacturing, and supply chain operations. Prior to joining Alcami, Jamie was Chief Manufacturing Officer at Istari Oncology. He has served multiple manufacturing and operations leadership roles throughout his career including executive roles at Xellia Pharmaceuticals, Pfizer, and Hospira.
Katie brings over 25 years of experience in leading laboratory teams. Before returning to Alcami in June 2020, Katie worked for two years at Avista Pharma Solutions/Cambrex where she led the Analytical Development Service team to over 46% year over year growth. She started her career with AAIPharma (now Alcami) in Wilmington as an Assistant Scientist and has progressed through every level of the career ladder. While at AAIPharma, some of her many
Mr. Compton brings over twenty-five years of industry experience with an extensive background in leading commercial operations. Before joining Alcami, Mr. Compton was the Chief Commercial Officer at Avid Bioservices, Inc. (NASDAQ: CDMO), a contract large molecule bulk drug substance development and manufacturer. From 2015 to 2019, Mr. Compton was the Vice President of Sales and Marketing at Avista Pharma, a private equity-backed global provider of contract manufacturing, development, and analytical testing services acquired by Cambrex. Mr. Compton also served in numerous executive leadership roles at AAIPharma Services Corporation, a predecessor company to Alcami, from 2010 to 2014. During the first 10-years of his career, he supported small innovator biotech/pharma start-up companies, advancing drugs from discovery to the clinic. Prior to embarking on a career in commercial operations, his last scientific role was Director of Analytical Development at Kadmus Pharmaceuticals.
Timothy holds a B.S. in Microbiology from Washington State University and is an active duty veteran of the U.S. Army.
Jacque joined Alcami in January of 2020 as the Vice President of Quality Operations. Before joining Alcami, she was the Vice President of Quality at TriPharm Services and was responsible for all Quality and Compliance aspects of the company’s parenteral manufacturing operation and related testing. Before this, she used her depth of industry experience as a consultant for private equity firms. Prior to this, she oversaw the Quality and Compliance of externally manufactured Commercial sterile products for Gilead Sciences, which encompassed aseptic processing, blow-fill-seal, and medical device operations, which totaled sixteen sites globally. Before Gilead, she was the Site Head of quality for the AAIPharma aseptic manufacturing facility located in Charleston, SC. Jacque holds a Bachelor of Science degree in Biology from the University of South Carolina.
Laurent brings over 30 years of experience in general management, biologics manufacturing, domestic and international logistics, supply chain management, operations, and information technology expertise across multiple organizations. Laurent’s previous roles include VP and Site GM for Resilience (acquired from Sanofi in March 2021) and VP/GM at Genzyme including serving from 2011 – 2017 as General Manager of the Northborough, MA Operations Center. Prior to Genzyme, he lived in Belgium from 2007 – 2011 and served as Vice-President Global Supply Chain in Brussels, Belgium, for UCB Pharma, and Director of Global Supply Chain for Biogen Idec in Cambridge. Laurent started his career at United Parcel Service as an Industrial Engineering Manager. Laurent’s educational credentials include a Master of Science (Drs.) in Business Econometrics from Erasmus Universiteit, Rotterdam, NL, with majors in Business Econometrics, Marketing and Operations Research. He also holds a Lean Six Sigma Green Belt certificate and a Masters Certificate in Project Management.